10:37 AM EDT, 10/15/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Wednesday its expanded manufacturing facility in Coppell, Texas, will double the production of Lokelma for hyperkalemia patients in the US and worldwide.

The $445 million expansion involved the construction of a new 9,000 square foot building that will support drug product laboratory testing and warehousing, the company said.

The expansion project is part of the company's $50 billion investment roadmap to boost research and manufacturing footprint in the US over the next five years, according to the company.

Price: 84.42, Change: -0.70, Percent Change: -0.82